166 related articles for article (PubMed ID: 22907527)
1. Single-dose pharmacokinetic and toxicity analysis of pyrrole-imidazole polyamides in mice.
Synold TW; Xi B; Wu J; Yen Y; Li BC; Yang F; Phillips JW; Nickols NG; Dervan PB
Cancer Chemother Pharmacol; 2012 Oct; 70(4):617-25. PubMed ID: 22907527
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of pyrrole-imidazole polyamides after intravenous administration in rat.
Fukasawa A; Aoyama T; Nagashima T; Fukuda N; Ueno T; Sugiyama H; Nagase H; Matsumoto Y
Biopharm Drug Dispos; 2009 Mar; 30(2):81-9. PubMed ID: 19226654
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of Py-Im polyamides depend on architecture: cyclic versus linear.
Raskatov JA; Hargrove AE; So AY; Dervan PB
J Am Chem Soc; 2012 May; 134(18):7995-9. PubMed ID: 22509786
[TBL] [Abstract][Full Text] [Related]
4. In vivo imaging of pyrrole-imidazole polyamides with positron emission tomography.
Harki DA; Satyamurthy N; Stout DB; Phelps ME; Dervan PB
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13039-44. PubMed ID: 18753620
[TBL] [Abstract][Full Text] [Related]
5. Cyclic pyrrole-imidazole polyamides targeted to the androgen response element.
Chenoweth DM; Harki DA; Phillips JW; Dose C; Dervan PB
J Am Chem Soc; 2009 May; 131(20):7182-8. PubMed ID: 19413319
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic modeling and prediction of plasma pyrrole-imidazole polyamide concentration in rats using simultaneous urinary and biliary excretion data.
Nagashima T; Aoyama T; Yokoe T; Fukasawa A; Fukuda N; Ueno T; Sugiyama H; Nagase H; Matsumoto Y
Biol Pharm Bull; 2009 May; 32(5):921-7. PubMed ID: 19420765
[TBL] [Abstract][Full Text] [Related]
7. Binding of hairpin pyrrole and imidazole polyamides to DNA: relationship between torsion angle and association rate constants.
Han YW; Matsumoto T; Yokota H; Kashiwazaki G; Morinaga H; Hashiya K; Bando T; Harada Y; Sugiyama H
Nucleic Acids Res; 2012 Dec; 40(22):11510-7. PubMed ID: 23042247
[TBL] [Abstract][Full Text] [Related]
8. Orientation preferences of hairpin pyrrole-imidazole polyamides toward
Sato S; Asamitsu S; Bando T; Sugiyama H
Bioorg Med Chem; 2019 Jun; 27(11):2167-2171. PubMed ID: 31000407
[TBL] [Abstract][Full Text] [Related]
9. Modifications at the C-terminus to improve pyrrole-imidazole polyamide activity in cell culture.
Jacobs CS; Dervan PB
J Med Chem; 2009 Dec; 52(23):7380-8. PubMed ID: 19572551
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the relative cellular permeability of DNA-binding pyrrole-imidazole polyamides.
Liu B; Kodadek T
J Med Chem; 2009 Aug; 52(15):4604-12. PubMed ID: 19610652
[TBL] [Abstract][Full Text] [Related]
11. Tumor xenograft uptake of a pyrrole-imidazole (Py-Im) polyamide varies as a function of cell line grafted.
Raskatov JA; Szablowski JO; Dervan PB
J Med Chem; 2014 Oct; 57(20):8471-6. PubMed ID: 25238175
[TBL] [Abstract][Full Text] [Related]
12. Characterization and solubilization of pyrrole-imidazole polyamide aggregates.
Hargrove AE; Raskatov JA; Meier JL; Montgomery DC; Dervan PB
J Med Chem; 2012 Jun; 55(11):5425-32. PubMed ID: 22607187
[TBL] [Abstract][Full Text] [Related]
13. Animal toxicity of hairpin pyrrole-imidazole polyamides varies with the turn unit.
Yang F; Nickols NG; Li BC; Szablowski JO; Hamilton SR; Meier JL; Wang CM; Dervan PB
J Med Chem; 2013 Sep; 56(18):7449-57. PubMed ID: 24015881
[TBL] [Abstract][Full Text] [Related]
14. A C-14 labeled Py-Im polyamide localizes to a subcutaneous prostate cancer tumor.
Raskatov JA; Puckett JW; Dervan PB
Bioorg Med Chem; 2014 Aug; 22(16):4371-5. PubMed ID: 24780272
[TBL] [Abstract][Full Text] [Related]
15. Sequence-specific DNA binding Pyrrole-imidazole polyamides and their applications.
Kawamoto Y; Bando T; Sugiyama H
Bioorg Med Chem; 2018 May; 26(8):1393-1411. PubMed ID: 29439914
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological properties of sequence-specific DNA-alkylating pyrrole-imidazole polyamides.
Bando T; Sugiyama H
Acc Chem Res; 2006 Dec; 39(12):935-44. PubMed ID: 17176032
[TBL] [Abstract][Full Text] [Related]
17. Anti-repression of RNA polymerase II transcription by pyrrole-imidazole polyamides.
Dickinson LA; Trauger JW; Baird EE; Ghazal P; Dervan PB; Gottesfeld JM
Biochemistry; 1999 Aug; 38(33):10801-7. PubMed ID: 10451376
[TBL] [Abstract][Full Text] [Related]
18. Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases.
Matsuda H; Fukuda N; Ueno T; Tahira Y; Ayame H; Zhang W; Bando T; Sugiyama H; Saito S; Matsumoto K; Mugishima H; Serie K
J Am Soc Nephrol; 2006 Feb; 17(2):422-32. PubMed ID: 16371433
[TBL] [Abstract][Full Text] [Related]
19. Sequence-specific DNA binding by long hairpin pyrrole-imidazole polyamides containing an 8-amino-3,6-dioxaoctanoic acid unit.
Sawatani Y; Kashiwazaki G; Chandran A; Asamitsu S; Guo C; Sato S; Hashiya K; Bando T; Sugiyama H
Bioorg Med Chem; 2016 Aug; 24(16):3603-11. PubMed ID: 27301681
[TBL] [Abstract][Full Text] [Related]
20. Cell permeability of Py-Im-polyamide-fluorescein conjugates: Influence of molecular size and Py/Im content.
Nishijima S; Shinohara K; Bando T; Minoshima M; Kashiwazaki G; Sugiyama H
Bioorg Med Chem; 2010 Jan; 18(2):978-83. PubMed ID: 20022508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
